PharmaCyte Biotech, Inc. (PMCB) Insider Ownership

Historic Insider Ownership Trends

As of March 23, 2026, the three largest insider holders of PMCB are Joshua Silverman (Ceo And President, 416.25K shares), Jonathan Schechter (Director, 192.50K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Joshua Silverman Ceo And President 416,250 0 07 Jan, 2026
Jonathan Schechter 192,500 0 07 Jan, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
05 Jan, 2026 Joshua Silverman Common Stock A 30,000 $0.78 346,250 D P
05 Jan, 2026 Jonathan Schechter Common Stock A 20,000 $0.78 152,500 D P
06 Jan, 2026 Joshua Silverman Common Stock A 30,000 $0.79 376,250 D P
06 Jan, 2026 Jonathan Schechter Common Stock A 20,000 $0.79 172,500 D P
07 Jan, 2026 Jonathan Schechter Common Stock A 20,000 $0.84 192,500 D P
07 Jan, 2026 Joshua Silverman Common Stock A 40,000 $0.83 416,250 D P
12 Dec, 2025 Joshua Silverman Common Stock A 575,000 $0.00 575,000 D A
12 Dec, 2025 Joshua Silverman Common Stock D 258,750 $1.02 316,250 D F
20 Nov, 2023 Joshua Silverman Stock Option (Right to Buy) A 170,000 $0.00 170,000 D A
20 Nov, 2023 Wayne Remell Walker Stock Option (Right to Buy) A 61,248 $0.00 61,248 D A
20 Nov, 2023 Robert Weinstein Stock Option (Right to Buy) A 61,248 $0.00 61,248 D A
20 Nov, 2023 Carlos Trujillo Stock Option (Right to Buy) A 85,000 $0.00 85,000 D A
20 Nov, 2023 Jonathan Schechter Stock Option (Right to Buy) A 61,248 $0.00 61,248 D A
20 Nov, 2023 Michael M Abecassis Stock Option (Right to Buy) A 61,248 $0.00 61,248 D A
28 Dec, 2022 Daniel Stuart Farb Stock Option (Right to Buy) A 125,000 $0.00 125,000 D A
28 Dec, 2022 Daniel Allen Stock Option (Right to Buy) A 125,000 $0.00 125,000 D A